IDRA-21
CAS No. 22503-72-6
IDRA-21( —— )
Catalog No. M21086 CAS No. 22503-72-6
IDRA-21 is a positive AMPA receptor modulator.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 35 | Get Quote |
|
| 50MG | 58 | Get Quote |
|
| 100MG | 88 | Get Quote |
|
| 200MG | 140 | Get Quote |
|
| 500MG | 236 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameIDRA-21
-
NoteResearch use only, not for human use.
-
Brief DescriptionIDRA-21 is a positive AMPA receptor modulator.
-
DescriptionIDRA-21 is a positive AMPA receptor modulator.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayNeuroscience
-
TargetGluR
-
RecptorAMPA
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number22503-72-6
-
Formula Weight232.68
-
Molecular FormulaC8H9ClN2O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (1074.39 mM)
-
SMILESCC1Nc2ccc(Cl)cc2S(=O)(=O)N1
-
Chemical Name7-Chloro-3-methyl-3-4-dihydro-2H-124 benzothiadiazine SS-dioxide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Buccafusco J J Weiser T Winter K et al. The effects of IDRA 21 a positive modulator of the AMPA receptor on delayed matching performance by young and aged rhesus monkeys[J]. Neuropharmacology 2004 46(1):10-22.
molnova catalog
related products
-
LY-2300559
LY-2300559 is an agonist of metabotropic glutamate receptor 2 (mGluR2) and can be used in studies about the treatment of migraine.
-
ML 254
ML254 competitively interacts with the MPEP allosteric binding site. ML254 is highly selective for mGlu5 versus other mGlu receptors, has a clean ancillary Ricerca profile, and suitable dystrophia myotonica protein kinase (DMPK) properties for systemic dosing in rodents.
-
L-Cysteinesulfinic a...
L-Cysteinesulfinic acid monohydrate is a potent agonist at rat metabotropic glutamate receptors (mGluRs).
Cart
sales@molnova.com